International Coverage

Natural Alternatives International (NASDAQ:NAII) Coverage Initiated by Analysts at StockNews.com


Research analysts at StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAIIGet Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock.

Natural Alternatives International Price Performance

NASDAQ:NAII opened at $5.97 on Monday. The firm has a market capitalization of $37.01 million, a price-to-earnings ratio of -10.66 and a beta of 0.56. The company has a quick ratio of 2.44, a current ratio of 3.98 and a debt-to-equity ratio of 0.11. Natural Alternatives International has a 12-month low of $5.06 and a 12-month high of $7.62. The stock’s 50 day moving average price is $6.16 and its two-hundred day moving average price is $6.21.

Natural Alternatives International (NASDAQ:NAIIGet Free Report) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($0.27) EPS for the quarter. The company had revenue of $25.14 million for the quarter. Natural Alternatives International had a negative return on equity of 3.81% and a negative net margin of 2.75%.

Natural Alternatives International Company Profile

(Get Free Report)

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.

Read More



Receive News & Ratings for Natural Alternatives International Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Natural Alternatives International and related companies with MarketBeat.com’s FREE daily email newsletter.


Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button